Patients receiving a series of infusions of Remicade also maintained a response to treatment for longer (40 weeks) than those receiving placebo (14 weeks).
Remicade infusioonide seeria saanud patsientidel püsis ravivastus ka kauem (40 nädalat) kui platseebot saanud patsientidel (14 nädalat).